Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK.
Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Exp Hematol. 2022 Jan;105:18-21. doi: 10.1016/j.exphem.2021.11.004. Epub 2021 Nov 18.
Bone marrow failure syndromes encompass a range of inherited and acquired hematological diseases that result in insufficient blood cell production, which leads to severe complications including anemia, weakening of the immune system, impaired coagulation, and increased risk of cancer. Within inherited bone marrow failure syndromes, a number of genetically distinct diseases have been described including Shwachman-Diamond syndrome and Fanconi anemia. Given the genetic complexity and poor prognosis of these inherited bone marrow failure syndromes, there is increasing interest in both characterizing the genetic landscapes of these diseases and developing novel gene therapies to effectively monitor and cure patients. These topics were the focus of the winter 2021 International Society for Experimental Hematology New Investigator Webinar, which featured presentations by Dr. Akiko Shimamura and Dr. Paula Río. Here, we review the topics covered within this webinar.
骨髓衰竭综合征包括一系列遗传性和获得性血液疾病,导致血细胞生成不足,从而导致严重并发症,包括贫血、免疫系统减弱、凝血功能障碍以及癌症风险增加。在遗传性骨髓衰竭综合征中,已经描述了许多具有不同遗传特征的疾病,包括 Shwachman-Diamond 综合征和 Fanconi 贫血。鉴于这些遗传性骨髓衰竭综合征的遗传复杂性和预后不良,人们越来越关注对这些疾病的遗传图谱进行特征描述,并开发新的基因疗法来有效监测和治疗患者。这些主题是 2021 年冬季国际实验血液学会新研究员网络研讨会的重点,该研讨会由 Akiko Shimamura 博士和 Paula Río 博士的演讲组成。在这里,我们回顾了该网络研讨会涵盖的主题。